Diana Kerwin
Geriatric Medicine · Dallas, TXNPI 1750335097
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $68,245 of the $80,624 with a category attached, or 84.6%. 15 manufacturers reported payments, led by Eisai Inc. at 46.1% of the total. Reporting peaked in 2023 at $28,312 and has fallen 85.6% since, to $4,073 in 2025. Among geriatric medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $983.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$37K
- F. Hoffmann-la Roche AG$11K
- Genentech USA, Inc.$9K
- Lilly USA, LLC$8K
- Biogen$8K
- Novo Nordisk$3K
- plus $4K from 9 others
Across 483 payments — averaging $26,289 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7.6M
- AbbVie$1.4M
- Eisai Inc.$1.4M
- Genentech, Inc.$916K
- E.r. Squibb & Sons, L.L.C.$459K
- Novartis$366K
- plus $559K from 7 others
What the payments were for
- Consulting fees$68,24585%
- Speaking & faculty fees$5,4547%
- Travel & lodging$3,5284%
- Food & beverage$2,8284%
- Education$5701%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 29 | $37,169 |
| F. Hoffmann-la Roche AG | 9 | $10,540 |
| Genentech USA, Inc. | 8 | $9,395 |
| Lilly USA, LLC | 13 | $8,218 |
| Biogen | 11 | $8,133 |
| Novo Nordisk | 2 | $2,932 |
| Genentech, Inc. | 1 | $1,610 |
| Acadia Pharmaceuticals Inc | 1 | $1,550 |
| Roche Products Limited | 2 | $667 |
| Hoffmann-la Roche Limited | 1 | $139 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Kls-martin L.p. | 1 | $98 |
| C2n Diagnostics, LLC | 1 | $25 |
| GE HealthCare | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$30,032
- KISUNLA$7,200
- Non-Covered Product$2,827
- NUPLAZID$1,550
How this compares
$80,624 in reported general payments places this provider in the 95th percentile of 275 geriatric medicine providers in Texas.
Other geriatric medicine in Dallas
- Jennifer AdamsDallas$1K
- Joseph BenenateDallas$1K
- Robert HaddoxDallas$1K
- Mauricio Gonzalez-AriasAustin$825K
- Eberenne IgbokwePearland$124K
- David SmithBrownwood$19K
- Alejandro ArizmendiHelotes$15K
- Rosa VizcarraSan Antonio$9K
- George TaffetHouston$9K
- John CarrollCorpus Christi$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.